UCLA Grad Cured of Sickle Cell with New Gene Therapy

Samuel Idahosa, 24, endured monthly hospitalizations and excruciating pain from sickle cell disease since childhood.

After receiving groundbreaking gene therapy at UCLA Health in 2025, he's now considered cured.